CurieBio is a technology company specializing in the development of AI-driven software solutions for the life sciences industry. The company leverages machine learning to accelerate drug discovery and development, enabling researchers to predict and optimize small molecule properties, protein structures, and biological outcomes.

Curie.Bio

CurieBio

Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.

No one understands the needs of a biotech founder better than someone who just went through their own founder journey. Curie.Bio is proud to welcome Leah Sibener, Ph.D. to the CSO Partner Team as a copilot for founders. Leah co-founded and built 3T Biosciences, a therapeutics company spinout leveraging her Ph.D. work in Chris Garcia's lab at Stanford. To learn more about Leah and how she'll support founders, read her bio at the link below.

https://lnkd.in/e_kzC6XR

Join us at the 2024 Convergence Forum, where Curie.Bio CEO Zach Weinberg will be speaking alongside Steve Pagliuca (Arena Bioworks) and Daphne Zohar (PureTech Health) to discuss new models for launching therapeutics companies. 

Meeting agenda → https://lnkd.in/eqtP66Au

We're thrilled to welcome Dallas Jones to our CSO Partner Team as a copilot for the founders of our portfolio companies. Dallas provides a wealth of experience after leading multiple programs from early-stage drug discovery through clinical development in Immunology and Neuroscience through his experience at Merck and Abide Therapeutics. He also supported the launch of multiple Series A therapeutics companies at Inception Sciences, the discovery engine of Versant Ventures. To learn more about Dallas and how he'll support founders, read his bio at the link below.

https://lnkd.in/eDzkV-4q

After an illustrious career bringing 11 drugs to the clinic, we're proud to announce Darryl B. McConnell has joined Curie.Bio as a CXO in Residence to help founders of our portfolio companies create successful medicines. To learn more about Darryl and how he'll be supporting founders, read his bio at the link below.

https://lnkd.in/eFCiv99K

"Do you have a therapeutic idea worthy of funding?" Our goal is to be every founder's first phone call. Whether you reach out through a warm intro or our website, you'll get specific and candid feedback from our team. At Curie.Bio, all ideas go through the same process regardless of where they come from. Connect with us at www.curie.bio

https://lnkd.in/ee4tA35i

BIO:CURIE

CurieBio

locale

market

industry

website

crunchbase

linkedin

peer of

investor of

competitor of

Metrics